NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Update: February 26

The domestic market ended with modest gains on Wednesday, February 26, with the Sensex rising 50 points, or 0.06%, to 82,276.07, and the Nifty 50 settling 58 points, or 0.23%, higher at 25,482.50.

According to Amol Athawale, VP - Technical Research at Kotak Securities, the 20-day SMA (simple moving average) of 25,600 may act as an immediate resistance for day traders. If the market trades below this level, a potential slip toward the 200-day SMA of 25,350-25,300 is likely.

Short-term Stock Picks

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

For the next 1-2 weeks, Amol Athawale recommends the following three stocks to buy:

Mahindra & Mahindra

  • Previous close: ₹3,491.30
  • Target price: ₹3,720
  • Stop loss: ₹3,360 The stock has rebounded from its important retracement zone and witnessed a robust recovery after declining from higher levels. A breakout from its sloping trendline suggests a new leg of the bullish trend.

DCB Bank

  • Previous close: ₹191.28
  • Target price: ₹205
  • Stop loss: ₹185 The stock is having a breather after a remarkable up move. A consolidation structure suggests bullish continuation chart formation, and the stock comfortably closed above its short-term moving average.

Fortis Healthcare

  • Previous close: ₹930.75
  • Target price: ₹990
  • Stop loss: ₹900 The stock has formed an inverse head and shoulder chart pattern and is trading near the neckline resistance zone. Rising volume activity and structure indicate a fresh leg of upward momentum from current levels.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Investor Takeaway

Investors should be cautious and consider short-term selling opportunities in the market.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.